Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | YMAB | Common Stock | Award | $0 | +4.66K | $0.00 | 4.66K | Mar 12, 2024 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | YMAB | Stock Option (right to buy) | Award | $0 | +27.9K | $0.00 | 27.9K | Mar 12, 2024 | Common Stock | 27.9K | $16.09 | Direct | F2, F3 |
Id | Content |
---|---|
F1 | Represents 4,660 restricted stock units ("RSUs") granted to the Reporting Person as a non-employee director pursuant to the 2018 Equity Incentive Plan of Y-mAbs Therapeutics, Inc. Each RSU represents a contingent right to receive one share of Common Stock on the vesting date of the RSUs. The RSUs vest in equal quarterly installments over a three-year period measured from three months following March 12, 2024, subject to the Reporting Person's continued service through each applicable vesting date. |
F2 | Stock options granted to the Reporting Person as a non-employee director pursuant to the 2018 Equity Incentive Plan of Y-mAbs Therapeutics, Inc. |
F3 | The stock option shall vest and become exercisable in equal monthly installments over a three-year period measured from one month following March 12, 2024, subject to the Reporting Person's continued service through each applicable vesting date. |